Viewsroom Podcast Por Reuters arte de portada

Viewsroom

Viewsroom

De: Reuters
Escúchala gratis

Breakingviews columnists talk about the big numbers, crunchy deals and nasty spats in global business and economics, offering a weekly dose of financial insight that goes beyond the concise and provocative views readers get from our columns every day.WW Política y Gobierno
Episodios
  • Revived dealmakers confront resurgent challenges

    Revived dealmakers confront resurgent challenges
    Apr 2 2026
    The mega-merger boom persists with Unilever’s $65 bln mayo-to-mustard combo while beauty giant Estée Lauder holds talks with Puig. In this week’s Viewsroom, Breakingviews columnists debate whether the good times will keep rolling or if CEOs will get spooked by oil prices and AI. M&A jamboree swings to syncopated rhythm Pernod and Jack Daniel’s would be a stiff cocktail Estée Lauder’s Puig approach fails the smell test Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    25 m
  • Novo Nordisk is Denmark’s big little problem

    Novo Nordisk is Denmark’s big little problem
    Mar 26 2026
    As war rages and Donald Trump looms, a recent election featured little mention of the ailing $164 bln drugmaker, once so successful it distorted economic figures. In this week’s Viewsroom, Breakingviews columnists discuss the future of weight loss pills, and Novo’s place in it. Novo Nordisk's illness offers painful lessons Novo Nordisk’s falling knife is still gathering speed Obesity pills are shaky Hail Mary for Novo Nordisk Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    22 m
  • The AI boom tests its limits

    The AI boom tests its limits
    Mar 19 2026
    OpenAI and Anthropic, together valued at over $1 trln, have raised vast sums from a panoply of backers in the thus-far unprofitable quest to perfect silicon intelligence. In this week’s Viewsroom, Breakingviews columnists discern the signs that this enthusiasm is hard to sustain. What happens if OpenAI or Anthropic fail? Anthropic gives lesson in AI revenue hallucination Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    24 m
Todavía no hay opiniones